These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

711 related articles for article (PubMed ID: 23318455)

  • 1. Axl/Gas6/NFκB signalling in schwannoma pathological proliferation, adhesion and survival.
    Ammoun S; Provenzano L; Zhou L; Barczyk M; Evans K; Hilton DA; Hafizi S; Hanemann CO
    Oncogene; 2014 Jan; 33(3):336-46. PubMed ID: 23318455
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The p53/mouse double minute 2 homolog complex deregulation in merlin-deficient tumours.
    Ammoun S; Schmid MC; Zhou L; Hilton DA; Barczyk M; Hanemann CO
    Mol Oncol; 2015 Jan; 9(1):236-48. PubMed ID: 25217104
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting MERTK on tumour cells and macrophages: a potential intervention for sporadic and NF2-related meningioma and schwannoma tumours.
    Dave F; Herrera K; Lockley A; van de Weijer LL; Henderson S; Sofela AA; Hook L; Adams CL; Ercolano E; Hilton DA; Maze EA; Kurian KM; Ammoun S; Hanemann CO
    Oncogene; 2024 Oct; 43(41):3049-3061. PubMed ID: 39179860
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ponatinib promotes a G1 cell-cycle arrest of merlin/NF2-deficient human schwann cells.
    Petrilli AM; Garcia J; Bott M; Klingeman Plati S; Dinh CT; Bracho OR; Yan D; Zou B; Mittal R; Telischi FF; Liu XZ; Chang LS; Welling DB; Copik AJ; Fernández-Valle C
    Oncotarget; 2017 May; 8(19):31666-31681. PubMed ID: 28427224
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin-like growth factor-binding protein-1 (IGFBP-1) regulates human schwannoma proliferation, adhesion and survival.
    Ammoun S; Schmid MC; Zhou L; Ristic N; Ercolano E; Hilton DA; Perks CM; Hanemann CO
    Oncogene; 2012 Mar; 31(13):1710-22. PubMed ID: 21892205
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cross-phosphorylation, signaling and proliferative functions of the Tyro3 and Axl receptors in Rat2 cells.
    Brown JE; Krodel M; Pazos M; Lai C; Prieto AL
    PLoS One; 2012; 7(5):e36800. PubMed ID: 22606290
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Functional Role of GAS6/TAM in Nonalcoholic Steatohepatitis Progression Implicates AXL as Therapeutic Target.
    Tutusaus A; de Gregorio E; Cucarull B; Cristóbal H; Aresté C; Graupera I; Coll M; Colell A; Gausdal G; Lorens JB; García de Frutos P; Morales A; Marí M
    Cell Mol Gastroenterol Hepatol; 2020; 9(3):349-368. PubMed ID: 31689560
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dissecting and targeting the growth factor-dependent and growth factor-independent extracellular signal-regulated kinase pathway in human schwannoma.
    Ammoun S; Flaiz C; Ristic N; Schuldt J; Hanemann CO
    Cancer Res; 2008 Jul; 68(13):5236-45. PubMed ID: 18593924
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of insulin-like growth factors signaling in merlin-deficient human schwannomas.
    Ammoun S; Schmid MC; Ristic N; Zhou L; Hilton D; Ercolano E; Carroll C; Hanemann CO
    Glia; 2012 Nov; 60(11):1721-33. PubMed ID: 22821509
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Up-regulation of soluble Axl and Mer receptor tyrosine kinases negatively correlates with Gas6 in established multiple sclerosis lesions.
    Weinger JG; Omari KM; Marsden K; Raine CS; Shafit-Zagardo B
    Am J Pathol; 2009 Jul; 175(1):283-93. PubMed ID: 19541935
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TAM receptors Tyro3 and Mer as novel targets in colorectal cancer.
    Schmitz R; Valls AF; Yerbes R; von Richter S; Kahlert C; Loges S; Weitz J; Schneider M; Ruiz de Almodovar C; Ulrich A; Schmidt T
    Oncotarget; 2016 Aug; 7(35):56355-56370. PubMed ID: 27486820
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The GAS6-AXL signaling pathway triggers actin remodeling that drives membrane ruffling, macropinocytosis, and cancer-cell invasion.
    Zdżalik-Bielecka D; Poświata A; Kozik K; Jastrzębski K; Schink KO; Brewińska-Olchowik M; Piwocka K; Stenmark H; Miączyńska M
    Proc Natl Acad Sci U S A; 2021 Jul; 118(28):. PubMed ID: 34244439
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cellular prion protein (PrP
    Provenzano L; Ryan Y; Hilton DA; Lyons-Rimmer J; Dave F; Maze EA; Adams CL; Rigby-Jones R; Ammoun S; Hanemann CO
    Oncogene; 2017 Nov; 36(44):6132-6142. PubMed ID: 28692055
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gas6-induced tissue factor expression in endothelial cells is mediated through caveolin-1-enriched microdomains.
    Laurance S; Aghourian MN; Jiva Lila Z; Lemarié CA; Blostein MD
    J Thromb Haemost; 2014; 12(3):395-408. PubMed ID: 24354620
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pericyte FAK negatively regulates Gas6/Axl signalling to suppress tumour angiogenesis and tumour growth.
    Lechertier T; Reynolds LE; Kim H; Pedrosa AR; Gómez-Escudero J; Muñoz-Félix JM; Batista S; Dukinfield M; Demircioglu F; Wong PP; Matchett KP; Henderson NC; D'Amico G; Parsons M; Harwood C; Meier P; Hodivala-Dilke KM
    Nat Commun; 2020 Jun; 11(1):2810. PubMed ID: 32499572
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Receptor tyrosine kinases, TYRO3, AXL, and MER, demonstrate distinct patterns and complex regulation of ligand-induced activation.
    Tsou WI; Nguyen KQ; Calarese DA; Garforth SJ; Antes AL; Smirnov SV; Almo SC; Birge RB; Kotenko SV
    J Biol Chem; 2014 Sep; 289(37):25750-63. PubMed ID: 25074926
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential TAM receptor-ligand-phospholipid interactions delimit differential TAM bioactivities.
    Lew ED; Oh J; Burrola PG; Lax I; Zagórska A; Través PG; Schlessinger J; Lemke G
    Elife; 2014 Sep; 3():. PubMed ID: 25265470
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gas6 attenuates lipopolysaccharide‑induced TNF‑α expression and apoptosis in H9C2 cells through NF‑κB and MAPK inhibition via the Axl/PI3K/Akt pathway.
    Li M; Ye J; Zhao G; Hong G; Hu X; Cao K; Wu Y; Lu Z
    Int J Mol Med; 2019 Sep; 44(3):982-994. PubMed ID: 31524235
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The scaffold protein KSR1, a novel therapeutic target for the treatment of Merlin-deficient tumors.
    Zhou L; Lyons-Rimmer J; Ammoun S; Müller J; Lasonder E; Sharma V; Ercolano E; Hilton D; Taiwo I; Barczyk M; Hanemann CO
    Oncogene; 2016 Jun; 35(26):3443-53. PubMed ID: 26549023
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypoxia stabilizes GAS6/Axl signaling in metastatic prostate cancer.
    Mishra A; Wang J; Shiozawa Y; McGee S; Kim J; Jung Y; Joseph J; Berry JE; Havens A; Pienta KJ; Taichman RS
    Mol Cancer Res; 2012 Jun; 10(6):703-12. PubMed ID: 22516347
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.